Skip to main content
. 2022 May 27;12(6):488. doi: 10.3390/metabo12060488

Figure 4.

Figure 4

Schematic overview of the four canonical pathways dysregulated in human PCa tumorigenesis. Biofluid samples are extracted and analyzed to reflect changes in metabolites and enzymes for PCa biomarker discovery: Glycolysis (a), TCA cycle (b), de novo lipogenesis (c), and glycogenesis/glycogenolysis (d). Red font = increased metabolites/upregulated enzymes; Orange = decreased metabolites/downregulated enzymes. MCT = monocarboxylate transporter; HK = hexokinase; PGI = phosphoglucose isomerase; PFK = phosphofructokinase; ALD = aldolase; DHAP = dihydroxyacetone phosphate; GA3P = gyceraldehyde-3-phosphate; GA3PD = gyceraldehyde-3-phosphate dehydrogenase; PGK = phosphoglycerate kinase; 3PG = 3-phosphoglycerate; PGM = phosphoglyceromutase; ENO = enolase; PK = pyruvate kinase; LDH = lactate dehydrogenase; CS = citrate synthase; OAA = oxaloacetate; UDP = uridine diphosphate; UTP = uridine triphosphate. Figure drawn using BioRender [26].